Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CRBP – Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings
CRBP
$9.31
Name : Corbus Pharmaceuticals Holdings
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $114,416,184.00
EPSttm : -4.24
finviz dynamic chart for CRBP
Corbus Pharmaceuticals Holdings
$9.31
0.43%
$0.04

Float Short %

12.85

Margin Of Safety %

Put/Call OI Ratio

0.42

EPS Next Q Diff

0.03

EPS Last/This Y

-1.61

EPS This/Next Y

0.46

Price

9.31

Target Price

41.62

Analyst Recom

1

Performance Q

23.8

Relative Volume

0.79

Beta

3.21

Ticker: CRBP




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04CRBP7.60.320.881110
2025-07-07CRBP7.280.340.001136
2025-07-08CRBP7.540.330.001141
2025-07-09CRBP8.360.330.101143
2025-07-10CRBP8.360.330.001169
2025-07-11CRBP8.310.320.031183
2025-07-14CRBP8.390.320.221188
2025-07-15CRBP8.080.320.001187
2025-07-16CRBP8.550.320.001187
2025-07-17CRBP8.460.330.001186
2025-07-18CRBP8.510.320.001188
2025-07-21CRBP8.560.350.071039
2025-07-22CRBP8.670.343.501050
2025-07-23CRBP8.790.3710.671068
2025-07-24CRBP8.990.410.001099
2025-07-25CRBP9.170.400.331124
2025-07-28CRBP9.650.400.121144
2025-07-29CRBP9.250.384.501230
2025-07-30CRBP9.270.470.031340
2025-07-31CRBP9.310.420.001440
2025-08-01CRBP9.270.420.001440
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04CRBP7.71-47.6- -5.29
2025-07-07CRBP7.29-47.6- -5.29
2025-07-08CRBP7.54-47.6- -5.29
2025-07-09CRBP8.37-47.6- -5.29
2025-07-10CRBP8.36-47.6- -5.29
2025-07-11CRBP8.27-47.6- -5.29
2025-07-14CRBP8.36-47.6- -5.29
2025-07-15CRBP8.06-47.6- -5.29
2025-07-16CRBP8.58-47.6- -5.29
2025-07-17CRBP8.46-47.6- -5.29
2025-07-18CRBP8.51-47.6- -5.29
2025-07-21CRBP8.58-47.6- -5.29
2025-07-22CRBP8.72-47.6- -5.29
2025-07-23CRBP8.79-47.6- -5.29
2025-07-24CRBP9.01-47.6- -5.29
2025-07-25CRBP9.26-47.6- -5.29
2025-07-28CRBP9.67-47.6- -5.29
2025-07-29CRBP9.27-47.6- -5.29
2025-07-30CRBP9.26-47.6- -5.29
2025-07-31CRBP9.27-47.6- -5.29
2025-08-01CRBP9.31-47.6- -5.29
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04CRBP-1.31-8.3017.47
2025-07-07CRBP-1.31-8.3717.47
2025-07-08CRBP-1.31-8.3717.47
2025-07-09CRBP-1.31-8.3717.47
2025-07-10CRBP-1.31-8.3717.47
2025-07-11CRBP-1.31-8.3714.42
2025-07-14CRBP-1.31-8.5314.42
2025-07-15CRBP-1.31-8.5314.42
2025-07-16CRBP-1.31-8.5314.42
2025-07-17CRBP-1.31-8.5314.42
2025-07-18CRBP-1.31-8.5314.42
2025-07-21CRBP-1.31-7.1414.42
2025-07-22CRBP-1.31-7.1414.42
2025-07-23CRBP-1.31-7.1414.42
2025-07-24CRBP-1.31-7.1414.42
2025-07-25CRBP-1.31-7.1412.85
2025-07-28CRBP-1.31-13.2312.85
2025-07-29CRBP-1.31-13.2312.85
2025-07-30CRBP-1.31-13.2312.85
2025-07-31CRBP-1.31-13.2312.85
2025-08-01CRBP-1.31-13.2312.85
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-1.39

Avg. EPS Est. Current Quarter

-1.33

Avg. EPS Est. Next Quarter

-1.36

Insider Transactions

-1.31

Institutional Transactions

-13.23

Beta

3.21

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

16

Growth Score

22

Sentiment Score

49

Actual DrawDown %

96.8

Max Drawdown 5-Year %

-99.2

Target Price

41.62

P/E

Forward P/E

PEG

P/S

P/B

0.9

P/Free Cash Flow

EPS

-4.23

Average EPS Est. Cur. Y​

-5.29

EPS Next Y. (Est.)

-4.84

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.79

Return on Equity vs Sector %

-63.3

Return on Equity vs Industry %

-44.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Corbus Pharmaceuticals Holdings
Sector: Healthcare
Industry: Biotechnology
Employees: 28
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
stock quote shares CRBP – Corbus Pharmaceuticals Holdings, Inc. Stock Price stock today
news today CRBP – Corbus Pharmaceuticals Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CRBP – Corbus Pharmaceuticals Holdings, Inc. yahoo finance google finance
stock history CRBP – Corbus Pharmaceuticals Holdings, Inc. invest stock market
stock prices CRBP premarket after hours
ticker CRBP fair value insiders trading